Skip to content
WeighLab
Menu
Ranked #267 · Grade C

Lean Rx review

Lean Rx is a Sacramento-based telehealth technology platform offering compounded GLP-1 weight loss medications.

Visit Lean Rx Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$266/mo (starting dose, compounded)
Tirzepatide
$399/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Semaglutide · modeled / year

$3,192

Tirzepatide · modeled / year

$4,788

The Index scorecard

Lean Rx scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month46/100
Price Transparency78/100
Nationwide Access24/100
Formulation Options77/100
Clinical Oversight80/100
Contract Flexibility55/100

Where the value is

  • Both semaglutide and tirzepatide offered
  • Three formulations: injectable, sublingual, and tablet
  • Upfront pricing with no hidden fees advertised
  • Semaglutide starts at a low $266/month
  • Telehealth call with a licensed provider before prescribing

The tradeoffs

  • Compounded-only; no FDA-approved branded options
  • No published state availability list
  • Platform is technology only, not a healthcare provider itself
  • Provider credentials not detailed on site

The bottom line

Best for: Patients wanting compounded GLP-1 in injectable, sublingual, or tablet form. Lean Rx is a Sacramento-based telehealth technology platform offering compounded GLP-1 weight loss medications.

Ranked #267 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Lean Rx.

The 19 programs nearest this one

Pricing, states and verification reflect Lean Rx's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Lean Rx's site. Not medical advice; see our disclosure.

← Back to the value leaderboard